These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5903112)

  • 21. Acceptability and antigenicity of adjuvant soluble sub-unit adenovirus vaccines in navy recruits.
    Rosenbaum MJ; Poudstone JW; Edwards EA
    Mil Med; 1976 Jun; 141(6):383-8. PubMed ID: 819862
    [No Abstract]   [Full Text] [Related]  

  • 22. Capsid mosaics of intermediate strains of human adenoviruses.
    Norrby E
    J Virol; 1969 Nov; 4(5):657-62. PubMed ID: 5360523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological identification of an Australian adenovirus isolate from sheep.
    Adair BM; McKillop ER; Coackley BH
    Aust Vet J; 1986 May; 63(5):162. PubMed ID: 3019292
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative studies of adenovirus hexon antigens.
    Nász I; Lengyel A; Cserba I
    Arch Gesamte Virusforsch; 1972; 36(1):80-92. PubMed ID: 4622265
    [No Abstract]   [Full Text] [Related]  

  • 25. Adenovirus soluble antigen vaccine studies. I. Preparation and testing of adenovirus type 5 soluble antigen vaccines.
    Metzgar DP; Thomas WJ; Insalaco CS; DeSanctis AN; Beiler JM
    Proc Soc Exp Biol Med; 1968 Jul; 128(3):679-83. PubMed ID: 5668108
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunoglobulin classes of neutralizing antibody formed after human inoculation with soluble adenoviral antigens.
    Lehrich JR; Kasel JA; Rossen RD
    J Immunol; 1966 Nov; 97(5):654-62. PubMed ID: 4162741
    [No Abstract]   [Full Text] [Related]  

  • 27. A search for a complement-fixing antibody in cancer patients against the tumor antigen of adenovirus type 12.
    Masuda T
    Gan; 1968 Feb; 59(1):79-82. PubMed ID: 4874890
    [No Abstract]   [Full Text] [Related]  

  • 28. Sensitization and neutralization of adenovirus by specific sera against capsid subunits.
    Wadell G
    J Immunol; 1972 Mar; 108(3):622-32. PubMed ID: 4110982
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigens and structure of the adenovirus.
    Valentine RC; Pereira HG
    J Mol Biol; 1965 Aug; 13(1):13-20. PubMed ID: 4955344
    [No Abstract]   [Full Text] [Related]  

  • 30. Persistence of neutralizing antibody in adult volunteers immunized with adnovirus soluble antigens.
    Banks PA; Kasel JA; Huber M; Alford RH; Knight V
    Proc Soc Exp Biol Med; 1966 Jan; 121(1):240-3. PubMed ID: 5902939
    [No Abstract]   [Full Text] [Related]  

  • 31. Observations on two new adenovirus serotypes with unusual antigenic characteristics.
    Blacklow NR; Hoggan MD; Austin JB; Rowe WP
    Am J Epidemiol; 1969 Dec; 90(6):501-5. PubMed ID: 5362858
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of the pathogenesis and antigenicity of infectious canine hepatitis virus and the A26-61 virus strain (Toronto).
    Swango LJ; Wooding WL; Binn LN
    J Am Vet Med Assoc; 1970 Jun; 156(12):1687-96. PubMed ID: 4316286
    [No Abstract]   [Full Text] [Related]  

  • 33. Structural proteins of adenoviruses. II. Purification and characterization of the adenovirus type 2 fiber antigen.
    Pettersson U; Philipson L; Höglund S
    Virology; 1968 Jun; 35(2):204-15. PubMed ID: 4970121
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunologic study of adenoviruses type 5, 7, 11, 14].
    Pierangeli L; Donati G; Tallarida G
    Boll Soc Ital Biol Sper; 1964 Mar; 40(6):235-7. PubMed ID: 5876691
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytotoxicity by antigen aggregation. Adenovirus neutralization assays as a model.
    Kjellén L
    Arch Gesamte Virusforsch; 1972; 39(1):1-12. PubMed ID: 4117915
    [No Abstract]   [Full Text] [Related]  

  • 36. An adenovirus isolated from sheep and its relationship to type 2 bovine adenovirus.
    Belák S; Pálfi V
    Arch Gesamte Virusforsch; 1974; 46(3-4):366-9. PubMed ID: 4451431
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study of the behavior of the soluble antigenic fraction (complement fixation) in cell cultures infected with adenovirus I].
    CHARDONNET Y; SOHIER R; PRUNIERAS M
    Rev Immunol Ther Antimicrob; 1961; 25():305-43. PubMed ID: 13878256
    [No Abstract]   [Full Text] [Related]  

  • 38. Distribution of antibody to bovine adenovirus type 1 in Alabama cattle, as determined by micro-serum-neutralization test.
    Rossi CR; Kiesel GK; Emrick VR
    Am J Vet Res; 1973 Jun; 34(6):841-2. PubMed ID: 4707570
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative serological studies with mammalian adenoviruses.
    Adair BM; McFerran JB
    Arch Virol; 1976; 51(4):319-25. PubMed ID: 61747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on in vitro neutralization of adenoviruses].
    KJELLEN L
    Arch Gesamte Virusforsch; 1957; 7(4):307-32. PubMed ID: 13521948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.